These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 19216298)

  • 1. Phase I study of a topical skin protectant against chemical warfare agents.
    Eisenkraft A; Krivoy A; Vidan A; Robenshtok E; Hourvitz A; Dushnitsky T; Markel G
    Mil Med; 2009 Jan; 174(1):47-52. PubMed ID: 19216298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermostyx (IB1) - High efficacy and safe topical skin protectant against percutaneous toxic agents.
    Dachir S; Barness I; Fishbine E; Meshulam J; Sahar R; Eisenkraft A; Amir A; Kadar T
    Chem Biol Interact; 2017 Apr; 267():25-32. PubMed ID: 27417258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A topical skin protectant against chemical warfare agents.
    Kadar T; Fishbine E; Meshulam J; Sahar R; Amir A; Barness I
    Isr Med Assoc J; 2003 Oct; 5(10):717-9. PubMed ID: 14719467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Getting the chemistry right in trials.
    Ramsay S
    Lancet; 1998 May; 351(9115):1528. PubMed ID: 10326533
    [No Abstract]   [Full Text] [Related]  

  • 5. Using the skin protective lotion IB1 as a substitute for chemical protective gloves.
    Ophir N; Milk N; Mayer T; Ravfogel S; Yavnai N; Eisenkraft A; Kadar T; Kassirer M; Rosman Y
    Am J Emerg Med; 2016 Oct; 34(10):1986-1990. PubMed ID: 27431736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technological advancements for the detection of and protection against biological and chemical warfare agents.
    Eubanks LM; Dickerson TJ; Janda KD
    Chem Soc Rev; 2007 Mar; 36(3):458-70. PubMed ID: 17325785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the ability of the topical skin protectant (TSP) to protect against contact dermatitis to urushiol (Rhus) antigen.
    Vidmar DA; Iwane MK
    Am J Contact Dermat; 1999 Dec; 10(4):190-7. PubMed ID: 10594293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
    Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
    Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a reactive topical skin protectant.
    Braue EH
    J Appl Toxicol; 1999 Dec; 19 Suppl 1():S47-53. PubMed ID: 10594901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot single centre, double blind, placebo controlled, randomized, parallel study of Calmagen® dermaceutical cream and lotion for the topical treatment of tinea and onychomycosis.
    Parekh M; Ramaiah G; Pashilkar P; Ramanujam R; Johnston P; Ilag LL
    BMC Complement Altern Med; 2017 Sep; 17(1):464. PubMed ID: 28923039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study.
    Fitch WP; Easterling WJ; Talbert RL; Bordovsky MJ; Mosier M
    J Sex Med; 2007 Mar; 4(2):477-84. PubMed ID: 17367443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study to determine the hemodynamic safety and feasibility of magnesium sulfate infusion in children with severe traumatic brain injury.
    Natale JE; Guerguerian AM; Joseph JG; McCarter R; Shao C; Slomine B; Christensen J; Johnston MV; Shaffner DH
    Pediatr Crit Care Med; 2007 Jan; 8(1):1-9. PubMed ID: 17251875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, part 1: guinea pigs challenged with VX.
    Braue EH; Smith KH; Doxzon BF; Lumpkin HL; Clarkson ED
    Cutan Ocul Toxicol; 2011 Mar; 30(1):15-28. PubMed ID: 20942572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimisation of a dosing regime for a topical skin protectant (barrier cream).
    Chilcott RP; Larner J; Matar H; Kansagra S; Theivendran B; Viegas VA; Goldman VS
    Cutan Ocul Toxicol; 2015; 34(4):327-34. PubMed ID: 25597377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.
    Angiolillo DJ; Hwang C; Datto C; Desai B; Sostek M
    Clin Ther; 2011 Dec; 33(12):1883-93. PubMed ID: 22078153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of magnesium sulfate in acute organophosphate pesticide poisoning.
    Basher A; Rahman SH; Ghose A; Arif SM; Faiz MA; Dawson AH
    Clin Toxicol (Phila); 2013 Jan; 51(1):35-40. PubMed ID: 23311540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Historical overview of topical skin protectant development.
    Romano JA; Filbert MG
    J Appl Toxicol; 1999 Dec; 19 Suppl 1():S39. PubMed ID: 10594899
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of in vitro tests to assess the efficacy of formulations as topical skin protectants against organophosphorus compounds.
    Millerioux J; Cruz C; Bazire A; Polly V; Lallement G; Lefeuvre L; Josse D
    Toxicol In Vitro; 2009 Feb; 23(1):127-33. PubMed ID: 18951968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on 'Topical verapamil HCL, topical trifluoroperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study'.
    Levine L
    J Sex Med; 2007 Jul; 4(4 Pt 1):1081-2. PubMed ID: 17627753
    [No Abstract]   [Full Text] [Related]  

  • 20. Prehospital use of magnesium sulfate as neuroprotection in acute stroke.
    Saver JL; Starkman S; Eckstein M; Stratton SJ; Pratt FD; Hamilton S; Conwit R; Liebeskind DS; Sung G; Kramer I; Moreau G; Goldweber R; Sanossian N;
    N Engl J Med; 2015 Feb; 372(6):528-36. PubMed ID: 25651247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.